{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:11:22Z","timestamp":1791223882412,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.schres.2011.10.022","type":"journal-article","created":{"date-parts":[[2011,12,4]],"date-time":"2011-12-04T15:24:34Z","timestamp":1323012274000},"page":"187-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)"],"prefix":"10.1016","volume":"134","author":[{"given":"Lamiae","family":"Grimaldi-Bensouda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Rouillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Astruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Benichou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Falissard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Limosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Beaufils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Vaiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Verdoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yola","family":"Moride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Thibaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucien","family":"Abenhaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2011.10.022_bb0005","series-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR","author":"American Psychiatric Association","year":"2000"},{"issue":"8","key":"10.1016\/j.schres.2011.10.022_bb0010","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4088\/JCP.v68n0808","article-title":"Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study","volume":"68","author":"Bai","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2011.10.022_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.euroneuro.2004.07.003","article-title":"Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets","volume":"15","author":"Chue","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.schres.2011.10.022_bb0020","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1586\/ern.09.96","article-title":"Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study","volume":"9","author":"De la G\u00e1ndara","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.schres.2011.10.022_bb0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2147\/NDT.S5463","article-title":"Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia","volume":"6","author":"Di Lorenzo","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.schres.2011.10.022_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.schbul.a033316","article-title":"Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder","volume":"24","author":"Doering","year":"1998","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2011.10.022_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrd3079","article-title":"Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers","volume":"9","author":"Eichler","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.schres.2011.10.022_bb0040","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2011.10.022_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002306","article-title":"Risperidone versus other atypical antipsychotic medication for schizophrenia","volume":"3","author":"Gilbody","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.schres.2011.10.022_bb0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1742-7843.2006.pto_293.x","article-title":"Indications for propensity scores and review of their use in pharmacoepidemiology","volume":"98","author":"Glynn","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.schres.2011.10.022_bb0055","series-title":"ECDEU Assessment Manual for Psychopharmacology, revised","first-page":"217","article-title":"Clinical global impression","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2011.10.022_bb0145","doi-asserted-by":"crossref","first-page":"s78","DOI":"10.1192\/bjp.191.50.s78","article-title":"Measurement of long-term outcomes in observational and randomised controlled trials","volume":"50","author":"Hodgson","year":"2007","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"6","key":"10.1016\/j.schres.2011.10.022_bb0065","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.160.6.1125","article-title":"Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic","volume":"160","author":"Kane","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.10.022_bb0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1192\/bjp.bp.105.017020","article-title":"Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder: randomised, controlled, open-label study","volume":"191","author":"Keks","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2011.10.022_bb0075","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"linical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators, 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.schres.2011.10.022_bb0080","first-page":"23","article-title":"A prospective study comparing the long-term effectiveness of injectable risperidone long-acting therapy and oral aripiprazole in patients with schizophrenia","volume":"7","author":"Macfadden","year":"2010","journal-title":"Psychiatry (Edgemont)"},{"issue":"2\u20133","key":"10.1016\/j.schres.2011.10.022_bb0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-9964(01)00325-5","article-title":"Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients","volume":"57","author":"Montout","year":"2002","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2011.10.022_bb0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0447.2006.00982.x","article-title":"The case for long-acting antipsychotic agents in the post-CATIE era","volume":"115","author":"Nasrallah","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"issue":"1\u20133","key":"10.1016\/j.schres.2011.10.022_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.schres.2008.11.007","article-title":"Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study","volume":"108","author":"Novick","year":"2009","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.schres.2011.10.022_bb0100","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1185\/03007990903149306","article-title":"e-STAR Study Group, 2009. Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry","volume":"25","author":"Olivares","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.schres.2011.10.022_bb0105","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"5","key":"10.1016\/j.schres.2011.10.022_bb0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/NDT.S3311","article-title":"Risperidone long-acting injection: a review of its long term safety and efficacy","volume":"4","author":"Rainer","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"9","key":"10.1016\/j.schres.2011.10.022_bb0150","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMoa1005987","article-title":"Long-acting risperidone and oral antipsychotics in unstable schizophrenia","volume":"364","author":"Rosenheck","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.schres.2011.10.022_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2753\/IMH0020-7411380400","article-title":"The French Mental Health System","volume":"38","author":"Rouillon","year":"2009","journal-title":"Int. J. Ment. Health"},{"issue":"Suppl 20","key":"10.1016\/j.schres.2011.10.022_bb0125","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2011.10.022_bb0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7326\/0003-4819-151-3-200908040-00125","article-title":"Comparative effectiveness research: a report from the Institute of Medicine","volume":"151","author":"Sox","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.schres.2011.10.022_bb0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10198-009-0215-9","article-title":"The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden","volume":"11","author":"Willis","year":"2010","journal-title":"Eur. J. Health Econ."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411005573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411005573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:23:18Z","timestamp":1760296998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996411005573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":27,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0920996411005573"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2011.10.022","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2011.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}